The pharmacokinetics of eflornithine (α-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness

By Na-Bangchang K.   Doua F.   Konsil J.   Hanpitakpong W.   Kamanikom B.   Kuzoe F.  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 4, 2004-06 ,pp. : 269-278

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis and In Vitro Evaluation of Tropane Halogenated-derivatives Against Malaria, Sleeping Sickness, Chagas Disease and Leishmaniasis

By  

Medicinal Chemistry, Vol. 10, Iss. 8, 2014-12 ,pp. : 753-758

Bentham Science Publishers

Access to resources Recommend Favorite

New Bicyclic Amines: Synthesis and SARs of their Action Against the Causative Organisms of Malaria and Sleeping Sickness

By  

Current Medicinal Chemistry, Vol. 16, Iss. 11, 2009-04 ,pp. : 1426-1441

Bentham Science Publishers

Access to resources Recommend Favorite

Nifurtimox + eflornithine promising for trypanosomiasis

By  

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Development of eflornithine [difluoromethylornithine, DFMO] has been discontinued

By  

Inpharma, Vol. 1, Iss. 1424, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite